|
Volumn 31, Issue 1-2, 1999, Pages 95-
|
Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival
a a,b a,b a,b a,b a,b a,b a,b a,b
b
BIOGEN
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
CD40 ANTIGEN;
IMMUNOGLOBULIN;
ALLOGRAFT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BLOOD TRANSFUSION;
CONFERENCE PAPER;
CONTROLLED STUDY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOTHERAPY;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD40;
CD40 LIGAND;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOSUPPRESSION;
LIGANDS;
LYMPHOCYTES;
MACACA FASCICULARIS;
MEMBRANE GLYCOPROTEINS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0345320251
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01455-9 Document Type: Conference Paper |
Times cited : (13)
|
References (4)
|